Author: News Room
Dublin, Aug. 29, 2024 (GLOBE NEWSWIRE) — The “Alfalfa Hay – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.The global market for Alfalfa Hay was estimated at 248.1 Million Metric Tons in 2023 and is projected to reach 345.3 Million Metric Tons by 2030, growing at a CAGR of 4.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The quality of alfalfa hay is significantly influenced by cultivation and harvesting techniques. Optimal growing conditions include well-drained soils with a neutral pH, adequate…
Dublin, Aug. 29, 2024 (GLOBE NEWSWIRE) — The “Ultra-High Strength Steel – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.The global market for Ultra-High Strength Steel was estimated at US$19.9 Billion in 2023 and is projected to reach US$27.3 Billion by 2030, growing at a CAGR of 4.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. In the automotive sector, the use of UHSS is pivotal in enhancing vehicle safety and efficiency. The material’s high strength allows for the design of thinner,…
BASEL, Switzerland, Aug. 29, 2024 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital & Research Centre (KFSHRC) successfully concluded its participation in the Association for Medical Education in Europe (AMEE) 2024 Conference, which commenced last Monday in Basel, Switzerland. The three-day event provided a platform for KFSHRC to showcase its expertise in employing the latest technologies in medical education, including virtual simulation and interactive learning tools, to a global audience of experts and specialists in medical education and healthcare. As an AMEE 2024 Gold Sponsor, KFSHRC’s booth attracted significant interest from visitors and experts who explored innovative medical education technologies and…
VICTORIA, Seychelles, Aug. 29, 2024 (GLOBE NEWSWIRE) — Bitget Wallet, a global leader in the Web3 wallet space, now supports USDT on the TON chain, allowing users to manage, transfer, deposit, and swap USDT on the TON chain. With this enhanced token swap feature, users can trade any tokens with USDT on the TON chain, and the cross-chain swaps enable trading of USDT between the TON chain and 14 other chains, including Ethereum, Solana and Base. This enhancement significantly strengthens Bitget Wallet’s trading capabilities within the TON ecosystem, meeting the growing demands of the community. The TON ecosystem has seen…
NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an operational update and reported financial results for the period ended June 30, 2024. Mesoblast Chief Executive Silviu Itescu said: “During the past year we have built significant momentum in our interactions with the United States Food and Drug Administration (FDA) across each of our Phase 3 products. I am very pleased that our Biologics License Application (BLA) resubmission for approval of Ryoncil® (remestemcel-L) in the treatment of children with steroid-refractory acute graft versus host disease (SR-aGVHD)…
Seattle – WA, Aug. 28, 2024 (GLOBE NEWSWIRE) — The KD Hall Foundation is honored to present “Resilient Hearts: Sickle Cell Education & Blood Donation,” a transformative event dedicated to raising awareness and fostering support for those affected by sickle cell disease. The blood drive and fireside conversation will take place on Wednesday, September 11, 2024, and promises to be a day of community engagement, education, and inspiration from our Sickle Cell Community. This impactful event will feature a community blood drive from 10:00 AM to 4:00 PM, offering attendees a chance to make a tangible difference in the lives…
NEWPORT BEACH, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) — Talonvest Capital, Inc. is proud to announce the recent closing of a $22,255,000 non-recourse, bank-funded, permanent loan for a Class A self storage portfolio on behalf of The Jenkins Organization and Clark Investment Group. The three Texas properties located in Dallas (1) and Austin (2) were delivered in 2018 and contain 253,425 NRSF across 2,118 climate, non-climate, and drive-up units. The 5-year fixed rate loan and longer than normal open window for prepayment gives the ownership future flexibility, interest-only payments for the full loan term maximizes cash yields, and the loan…
FLORIDA, N.Y., Aug. 28, 2024 (GLOBE NEWSWIRE) — Remee Wire & Cable, a leading manufacturer of electronic wire and cable, announced the expansion of their PowerPipe™ cables with the addition of a series of new copper multipair cables rated CL4Z for OSP (outside plant), direct burial, and wet location applications. These PowerPipe™ distribution cables are now available as part of Remee’s larger line of Activate™ Powered Cable Solutions. These new PowerPipe™ Class 4 Fault-Managed Power distribution cables are rated CL4Z and certified to UL 1400-2. The new PowerPipe™ cables have a 450V rating and include a variety of conductor pairs…
NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) — The New York Latino Film Festival (NYLFF), the nation’s premier Latino film festival, kicks off Latino Heritage Month from September 15 to 22, 2024, with an impressive roster of more than 13 films from nearly 20 countries, to be held, once again, at Regal Union Square (850 Broadway, NYC). Opening Night will be held for the first time at Audible’s Minetta Lane Theatre (18 Minetta Lane, NYC), Audible’s creative home for live performances in New York. This year’s Festival opens with the World Premiere of Clemente (2024, 101 min., USA), directed by…
SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) — Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Verve Therapeutics, Inc. (NASDAQ: VERV) securities between August 9, 2022 and April 1, 2024. Verve is a “clinical-stage genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines.” For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that Verve Therapeutics,…